Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia.
Beran M, Estey E, O'Brien S, Cortes J, Koller CA, Giles FJ, Kornblau S, Andreeff M, Vey N, Pierce SR, Hayes K, Wong GC, Keating M, Kantarjian H.
Beran M, et al. Among authors: giles fj.
J Clin Oncol. 1999 Sep;17(9):2819-30. doi: 10.1200/JCO.1999.17.9.2819.
J Clin Oncol. 1999.
PMID: 10561358
Clinical Trial.